Smith & Nephew plc (LON:SN) has received an average recommendation of “Hold” from the eleven ratings firms that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is GBX 1,317.30 ($17.33).
Several equities research analysts have weighed in on SN shares. Berenberg Bank restated a “hold” rating and issued a GBX 1,340 ($17.62) target price on shares of Smith & Nephew plc in a research note on Friday, November 3rd. Deutsche Bank AG raised their target price on shares of Smith & Nephew plc from GBX 1,200 ($15.78) to GBX 1,315 ($17.30) and gave the company a “hold” rating in a research note on Monday, October 23rd. J P Morgan Chase & Co raised their target price on shares of Smith & Nephew plc from GBX 1,280 ($16.84) to GBX 1,361 ($17.90) and gave the company a “neutral” rating in a research note on Monday, July 31st. Credit Suisse Group reiterated a “neutral” rating and set a GBX 1,280 ($16.84) price objective on shares of Smith & Nephew plc in a research note on Friday, July 28th. Finally, Jefferies Group LLC lifted their price objective on shares of Smith & Nephew plc from GBX 1,350 ($17.76) to GBX 1,515 ($19.93) and gave the stock a “buy” rating in a research note on Friday, July 28th.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://ledgergazette.com/2017/12/08/smith-nephew-plc-sn-receives-average-recommendation-of-hold-from-analysts.html.
Smith & Nephew plc (SN) opened at GBX 1,322 ($17.39) on Thursday. Smith & Nephew plc has a one year low of GBX 1,084 ($14.26) and a one year high of GBX 1,442 ($18.97).
About Smith & Nephew plc
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.